About Us
Our mission is to utilise and develop the intellectual property attached to Medical Patents owned by the company, with the intention of bringing clinical remediation to sufferers of mesothelioma and other asbestos related diseases.
The current focus of the company is to bring to clinical trials the patented invention and methodology, which is the subject of the company’s intellectual property, to ascertain the efficacy of the technology at ameliorating and possibly retarding the onset of mesothelioma in humans in the near future.
By exploiting the knowledge gained from over a decade of experimentation, we are seeking to undertake further bio-medical research and development with a view to creating novel drug treatments as well as expanding the scientific literature surrounding asbestos related diseases.
Our motto is "Ideas - Innovations - Treatments"
Medical Patents - IP - Grants
Medical Patent Information -
Title - Methods for the treatment and prevention of asbestos related diseases
Priority Date - 24/11/2014
Inventors - Jason Ravasini and Anthony George
Patent Application Number - AU2015354399
Country - AUSTRALIA
Title - Methods for the treatment and prevention of asbestos related diseases
Priority Date - 24/11/2014
Inventors - Jason Ravasini and Anthony George
Patent Application Number - US15/528707
Country - US
Title - Methods for the treatment and prevention of asbestos related diseases
Priority Date - 24/11/2014
Inventors - Jason Ravasini and Anthony George
Patent Application Number - EP15862201.9
Country - EU
IP Information -
The intellectual property attaching to the company’s ownership of the Medical Patents is 100% owned by Bio-Latem Technologies Pty Ltd.
Grants -
1 - Runner-up prize: Uniquest-UTS Trailblazer Ideas Award (2012).
2 - John T Reid Charitable Trusts (2011-14).
3 - SPARK Sydney (2014).
3 - One of only 12 international invitees to present the mesothelioma project idea at the BioInvestor Forum (San Francisco, Oct 2016).
4 - Hancock Prospecting P/L (2015-18).
Total Grants to date: $755,000
